Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
QuintilesIMS
Boehringer Ingelheim
Medtronic
Mallinckrodt
Teva
Argus Health
Baxter

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021196

« Back to Dashboard

NDA 021196 describes XYREM, which is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the XYREM profile page.

The generic ingredient in XYREM is sodium oxybate. There are one thousand four hundred and fifty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.
Summary for 021196
Tradename:XYREM
Applicant:Jazz Pharms
Ingredient:sodium oxybate
Patents:18
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021196
Suppliers and Packaging for NDA: 021196
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XYREM sodium oxybate SOLUTION;ORAL 021196 NDA Jazz Pharmaceuticals, Inc. 68727-100 68727-100-01 180 mL in 1 BOTTLE, PLASTIC (68727-100-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength500MG/ML
Approval Date:Jul 17, 2002TE:AARLD:Yes
Patent:➤ Sign UpPatent Expiration:Jul 4, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jul 4, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:Jun 16, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fuji
Mallinckrodt
Chubb
Dow
Colorcon
QuintilesIMS
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.